Alpine Immune Sciences
Stock Forecast, Prediction & Price Target
Alpine Immune Sciences Financial Estimates
Alpine Immune Sciences Revenue Estimates
Alpine Immune Sciences EBITDA Estimates
Alpine Immune Sciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $23.44M N/A | $30.06M 28.24% | $58.87M 95.83% | Avg: $20.20M Low: $17.39M High: $24.91M avg. -65.68% | Avg: $10.26M Low: $8.83M High: $12.66M avg. -49.18% | Avg: $48.51M Low: $41.75M High: $59.83M avg. 372.57% | Avg: $160.32M Low: $138.01M High: $197.75M avg. 230.50% |
Net Income
% change YoY
| $-50.33M N/A | $-57.76M -14.75% | $-32.18M 44.28% | Avg: $-110.19M Low: $-122.50M High: $-58.00M avg. -242.40% | Avg: $-148.78M Low: $-150.00M High: $-68.00M avg. -35.01% | Avg: $-107.50M Low: $-140.12M High: $-88.05M avg. 27.74% | Avg: $-57.50M Low: $-74.95M High: $-47.09M avg. 46.51% |
EBITDA
% change YoY
| $-49.60M N/A | $-54.95M -10.78% | $-43.67M 20.52% | Avg: $-19.15M Low: $-23.63M High: $-16.49M avg. 56.13% | Avg: $-9.73M Low: $-12.00M High: $-8.38M avg. 49.18% | Avg: $-46.00M Low: $-56.74M High: $-39.60M avg. -372.57% | Avg: $-152.04M Low: $-187.54M High: $-130.88M avg. -230.50% |
EPS
% change YoY
| -$1.98 N/A | -$1.73 12.62% | -$0.64 63.00% | Avg: -$1.76 Low: -$2.45 High: -$1.16 avg. -174.41% | Avg: -$2.24 Low: -$3 High: -$1.36 avg. -27.70% | Avg: -$2.15 Low: -$2.8 High: -$1.76 avg. 4.14% | Avg: -$1.15 Low: -$1.5 High: -$0.94 avg. 46.51% |
Operating Expenses
% change YoY
| $73.30M N/A | $88.21M 20.33% | $103.12M 16.90% | Avg: $33.15M Low: $28.53M High: $40.88M avg. -67.85% | Avg: $16.84M Low: $14.50M High: $20.77M avg. -49.18% | Avg: $79.60M Low: $68.52M High: $98.18M avg. 372.57% | Avg: $263.08M Low: $226.47M High: $324.49M avg. 230.50% |
FAQ
What is Alpine Immune Sciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -50.78% in 2025-2028.
We have gathered data from 5 analysts. Their low estimate is -122.50M, average is -110.19M and high is -58.00M.
What is Alpine Immune Sciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 122.05% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $17.39M, average is $20.20M and high is $24.91M.
What is Alpine Immune Sciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -37.86% in 2025-2028.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$2.45, average is -$1.76 and high is $-1.16.
What is the best performing analyst?
In the last twelve months analysts have been covering Alpine Immune Sciences stock. The most successful analyst is Robert Driscoll.